You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IPSS

Showing 1 - 25 of 1,008
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Canakinumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Lower Risk MDS Per IPSS-R Trial (Luspatercept)

Not yet recruiting
  • Lower Risk MDS Per IPSS-R
  • (no location specified)
Jun 21, 2023

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

Completed
  • Anemia in Myelodysplastic Syndromes
  • Plantation, Florida
  • +2 more
Apr 4, 2022

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Hefei, Anhui, China
    • +16 more
    Sep 6, 2022

    Anemia Trial (Luspatercept)

    Not yet recruiting
    • Anemia
    • Luspatercept
    • (no location specified)
    May 26, 2023

    Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

    Recruiting
    • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
    • Ocala, Florida
    • +3 more
    Jan 30, 2023

    Prostate Cancer, Radiotherapy Side Effect, Hypofractionation Trial in Quebec (grade and compare reported side effects between

    Recruiting
    • Prostate Cancer
    • +5 more
    • grade and compare reported side effects between groups
    • Quebec, Canada
      CHUdeQuebec
    Mar 14, 2023

    High Risk Myelodysplastic Syndrome, IPSS Risk Category Intermediate-1, Myelodysplastic Syndrome Trial in Houston (Azacitidine,

    Active, not recruiting
    Has Results
    • High Risk Myelodysplastic Syndrome
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 11, 2022

    MDS and Allogeneic Stem Cell Transplantation Trial in Perugia (MDS and AlloHSCT)

    Recruiting
    • MDS and Allogeneic Stem Cell Transplantation
    • MDS and AlloHSCT
    • Perugia, PG, Italy
      University of Perugia
    Mar 11, 2021

    Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)

    Active, not recruiting
    • Myelodysplastic Syndrome (MDS)
    • Brasschaat, Belgium
    • +9 more
    Jan 19, 2023

    Anemia, MDS Trial in Germany (Canakinumab Injection)

    Recruiting
    • Anemia
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Berlin, Germany
    • +5 more
    Nov 8, 2022

    MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Duarte, California
    • +46 more
    Jan 20, 2023

    MDS Trial in China, Japan (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
    • +33 more
    Aug 16, 2022

    MDS, CMML Trial in Florence (CC-486)

    Recruiting
    • MDS
    • CMML
    • Florence, Italy
      AOU Careggi- University of Florence
    Mar 16, 2021

    AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

    Recruiting
    • AML
    • +3 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 27, 2021

    Urinary Obstruction Trial in Sivas (IPP,IPSS,VPSS)

    Completed
    • Urinary Obstruction
    • IPP,IPSS,VPSS
    • Sivas, Turkey
      Cumhuriyet Universty
    Apr 30, 2021

    Acute Myeloid Leukemia With Multilineage Dysplasia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Blasts 20-30 Percent of

    Active, not recruiting
    • Acute Myeloid Leukemia With Multilineage Dysplasia
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 25, 2022

    COVID-19 (SARS-CoV-2) in Urine and Semen

    Completed
    • SARS-CoV 2
    • +4 more
    • SARS-CoV 2 RNA PCR Urine
    • +7 more
    • Florence, Tuscany, Italy
      AOU Careggi
    Oct 8, 2021

    MDS Trial in France, Germany (N-Plate / romiplostim)

    Completed
    • Myelodysplastic Syndromes
    • N-Plate / romiplostim
    • Annecy, France
    • +35 more
    Sep 7, 2021

    LURN SI-29 Questionnaire in Lower Urinary Tract Symptoms

    Unknown status
    • Lower Urinary Tract Symptoms
    • Urinary Incontinence
    • Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29)
    • +2 more
    • Istanbul, Turkey
      Istanbul Medeniyet University
    Jan 27, 2021

    Prostate Hyperplasia, Prostatic Hypertrophy, Surgery Trial (Holmium laser)

    Not yet recruiting
    • Prostate Hyperplasia
    • +5 more
    • Holmium laser
    • (no location specified)
    Aug 13, 2020

    Myelodysplastic Syndrome (MDS) Trial in United States (MBG453, Azacitidine, Decitabine)

    Recruiting
    • Myelodysplastic Syndrome (MDS)
    • Chandler, Arizona
    • +22 more
    Dec 5, 2022

    MDS Trial in United States (Pracinostat, Azacitidine)

    Terminated
    Has Results
    • Myelodysplastic Syndromes
    • Duarte, California
    • +24 more
    Feb 4, 2022